Profile
Guus Scheefhals worked as Manager-Business Development at DSM Biologics Holding, Inc. from 1999 to 2003.
From 2003 to 2010, served as Chief Business Officer at Avantium Technologies BV.
From 2010 to 2025, was Chief Executive Officer at Crossbeta Biosciences BV.
From 2018 to 2020, was Chief Executive Officer at DegenRx BV.
Completed graduate studies at the University of Utrecht.
Former positions of Guus Scheefhals
| Companies | Position | End |
|---|---|---|
Crossbeta Biosciences BV
Crossbeta Biosciences BV BiotechnologyHealth Technology Develops drug discovery programs in the area of misfolded protein diseases | Chief Executive Officer | 01/01/2025 |
DegenRx BV
DegenRx BV BiotechnologyHealth Technology Develops gene therapies for treatment of degenerative brain dieses | Chief Executive Officer | 01/09/2020 |
DSM Biologics Holding, Inc.
DSM Biologics Holding, Inc. BiotechnologyHealth Technology Manufactures biological and pharmaceutical products | Corporate Officer/Principal | - |
Avantium Technologies BV
Avantium Technologies BV Chemicals: SpecialtyProcess Industries Manufactures recyclable polymers | Chief Operating Officer | - |
Training of Guus Scheefhals
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Avantium Technologies BV
Avantium Technologies BV Chemicals: SpecialtyProcess Industries Manufactures recyclable polymers | Process Industries |
DSM Biologics Holding, Inc.
DSM Biologics Holding, Inc. BiotechnologyHealth Technology Manufactures biological and pharmaceutical products | Health Technology |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Crossbeta Biosciences BV
Crossbeta Biosciences BV BiotechnologyHealth Technology Develops drug discovery programs in the area of misfolded protein diseases | Health Technology |
DegenRx BV
DegenRx BV BiotechnologyHealth Technology Develops gene therapies for treatment of degenerative brain dieses | Health Technology |
- Stock Market
- Insiders
- Guus Scheefhals
















